| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.13 | 0.2 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.14 | 0.2 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.2 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |